We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Helen of Troy
HELE
$693M
| $48.8M | 0.11% |
271,291
+47,398
| +21% | +$7.6M |
|
177
Thermo Fisher Scientific
TMO
$220B
| $48.6M | 0.11% |
149,697
-59,983
| -29% | -$18.2M |
|
178
Federated Hermes
FHI
$4.72B
| $48.5M | 0.11% |
1,486,973
-125,954
| -8% | -$4.11M |
|
179
Mettler-Toledo International
MTD
$28.6B
| $48.5M | 0.11% |
61,078
-18,729
| -23% | -$13.5M |
|
|
UFS
180
DELISTED
DOMTAR CORPORATION (New)
UFS
| $48M | 0.11% |
1,254,526
+892,969
| +247% | +$33.1M |
|
|
STAY
181
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $47.8M | 0.11% |
3,214,059
-786,823
| -20% | -$11.5M |
|
|
AZPN
182
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $47.5M | 0.11% |
392,565
+129,272
| +49% | +$15.6M |
|
183
Regions Financial
RF
$26.8B
| $47.5M | 0.11% |
2,765,528
-1,508,905
| -35% | -$24.8M |
|
184
Flex
FLEX
$44.8B
| $47.3M | 0.11% |
4,973,657
+1,694,150
| +52% | +$14.6M |
|
185
AGCO
AGCO
$7.2B
| $47.1M | 0.11% |
609,561
+181,934
| +43% | +$14M |
|
|
CYBR
186
DELISTED
CyberArk
CYBR
| $47M | 0.11% |
403,515
+34,592
| +9% | +$3.88M |
|
187
Macerich
MAC
$6.92B
| $46.9M | 0.11% |
1,743,736
+1,205,731
| +224% | +$33.1M |
|
188
McKesson
MCK
$101B
| $46.9M | 0.11% |
+338,761
| New | +$47.9M |
|
189
CAE Inc. Common Shares
CAE
$8.74B
| $46.8M | 0.11% |
1,767,689
-283,818
| -14% | -$7.31M |
|
190
Howmet Aerospace
HWM
$112B
| $46.8M | 0.11% |
1,981,731
-857,892
| -30% | -$19.2M |
|
191
Xerox
XRX
$425M
| $46.4M | 0.11% |
1,258,043
+291,547
| +30% | +$10.2M |
|
192
Helmerich & Payne
HP
$3.71B
| $46.4M | 0.11% |
+1,020,426
| New | +$40.9M |
|
193
Macy's
M
$6.68B
| $46M | 0.11% |
2,708,146
+864,564
| +47% | +$13.5M |
|
194
Alkermes
ALKS
$8.25B
| $45.2M | 0.11% |
+2,215,587
| New | +$44M |
|
|
BBBY
195
DELISTED
Bed Bath & Beyond Inc
BBBY
| $44.6M | 0.1% |
2,576,680
+124,261
| +5% | +$1.74M |
|
|
TMX
196
DELISTED
Terminix Global Holdings, Inc.
TMX
| $44.5M | 0.1% |
1,151,983
+202,579
| +21% | +$8.61M |
|
197
Akamai
AKAM
$15.9B
| $44.4M | 0.1% |
+513,748
| New | +$44.9M |
|
198
Stryker
SYK
$130B
| $44.1M | 0.1% |
+210,253
| New | +$43.6M |
|
199
POSCO
PKX
$17.5B
| $44M | 0.1% |
869,889
+420,590
| +94% | +$20.3M |
|
200
Timken Company
TKR
$9.03B
| $43.9M | 0.1% |
778,884
+614,875
| +375% | +$31.1M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.